It’s Time to Staunch Our Self-Inflicted Wounds
Drug Topics
DECEMBER 6, 2024
Outside forces are at play, but pharmacists must turn inward to address some challenges in their profession.
Fri.Dec 06, 2024
187 
ASH 2024: Bispecific Antibodies Face Key Challenges for Implementation in Community Cancer Centers
Pharmacy Times
DECEMBER 6, 2024
Donald Moore discusses some of the obstacles that bispecific antibodies have faced in community cancer centers, including misconceptions coupled with a prevalent toxicity profile.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
STAT+: European regulators approve $16.5 billion deal for Novo Holdings to buy Catalent
STAT
DECEMBER 6, 2024
The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer. By taking this step, the executive arm of the European Union removed a significant obstacle to a deal that has generated debate over the extent to which competition in the pharmaceutical industry may be hindered.
USDA Announces Federal Order to Test Raw Milk Samples for H5N1 Bird Flu
Pharmacy Times
DECEMBER 6, 2024
The US Department of Agricultures (USDA) guidance will help expedite H5N1 bird flu surveillance within the nations milk supply and dairy herds.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Can you drink alcohol while taking clonidine?
The Checkup by Singlecare
DECEMBER 6, 2024
Clonidine is a generic medication that treats hypertension (high blood pressure). Because clonidine works differently than other blood pressure medications, it also has several off-label uses including anxiety, insomnia, attention deficit hyperactivity disorder (ADHD), and alcohol withdrawal. Clonidine, also sold under the brand name Catapres, is available as a tablet and once-a-week skin patch.
Don’t Ignore Erectile Dysfunction
Compounding Pharmacy of America
DECEMBER 6, 2024
Erectile dysfunction (ED) is often misunderstood as simply a sexual health concern, but it can signify much more. While many men experience occasional difficulties with sexual performance, persistent ED can be an early warning sign of serious underlying health issues such as cardiovascular disease, diabetes, or hormonal imbalances. Addressing ED is not just about improving […] The post Dont Ignore Erectile Dysfunction appeared first on Compounding Pharmacy of America.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready?
PharmaVoice
DECEMBER 6, 2024
Pharmacists Play Vital Role in Dietary Management
Drug Topics
DECEMBER 6, 2024
Researchers assessed the importance of a nutritious diet and the role pharmacists play in providing dietary management services.
FDA Grants Priory Review for Human Monoclonal Antibody Drug to Treat Muscle-Invasive Bladder Cancer
Pharmacy Times
DECEMBER 6, 2024
Durvalumab could offer further treatment for individuals with muscle-invasive bladder cancer.
FDA Roundup: ATX101 Gains Breakthrough Therapy Designation, Stelara Biosimilar Approval
Drug Topics
DECEMBER 6, 2024
Catch up on important FDA news from the week of December 2.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Minority Communities, Independent Storefronts Hit Hardest by Pharmacy Closures
Drug Topics
DECEMBER 6, 2024
Researchers observed data from 2010 to 2021 to better understand recent trends in US pharmacy closures and the specific pharmacy types that have been impacted.
With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close
Fierce Pharma
DECEMBER 6, 2024
Q&A: Pharmacist Discusses How High Rates of Chronic Pain Could Impact the Field
Drug Topics
DECEMBER 6, 2024
Madison Irwin, PharmD, BCPS, discusses her career pharmacy and how she thinks high rates of chronic pain will impact the field in the coming years.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
CDMO Resilience plots 105 layoffs at Florida plant it acquired in 2021
Fierce Pharma
DECEMBER 6, 2024
UnitedHealthcare CEO's death, wave of online anger likely to drive companies to rethink executive security
Fierce Healthcare
DECEMBER 6, 2024
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Generative AI is transforming radiology, and it’s only the beginning
STAT
DECEMBER 6, 2024
By 2030, agreed a roomful of radiologists in Chicago this week, generative AI will be ubiquitous in their written work. Medical imaging already leads the way in the clinical application of artificial intelligence: Algorithms that help to analyze CT scans, MRIs, and X-rays account for more than three-quarters of AI-based devices authorized by the Food and Drug Administration.
Eli Lilly to invest $3bn in Wisconsin facility expansion
Pharmaceutical Technology
DECEMBER 6, 2024
Eli has announced a $3bn investment to expand its newly acquired manufacturing facility in Kenosha County, Wisconsin, in the US.
Teva, Takeda sell generics joint venture in Japan to focus on innovative drugs
Fierce Pharma
DECEMBER 6, 2024
Experts Voice Concerns, Cautious Optimism With Kennedy Potentially Leading the HHS
Pharmacy Times
DECEMBER 6, 2024
As experts in medication management and health education, pharmacists can work with the administration to promote effective strategies that reduce misinformation and improve public health outcomes.
FDA shares new draft guidance for accelerated approval
Pharmaceutical Technology
DECEMBER 6, 2024
The new FDA guidance outlines how surrogate or intermediate clinical endpoints can support accelerated approval.
ASH 2024: Leukemia Biology Can Predict Patterns of Blinatumomab Failure in Patients with B-Cell ALL
Pharmacy Times
DECEMBER 6, 2024
Jose Tinajero discusses how certain mutations can be indicators of blinatumomab treatment failure in patients with B-cell acute lymphoblastic leukemia.
David O. Sacks, future White House AI Czar, likely to favor startups and 'thoughtful' regulation
Fierce Healthcare
DECEMBER 6, 2024
Long-Term Data On Olanzapine and Samidorphan Highlight Maintained Schizophrenia Symptom Control
Pharmacy Times
DECEMBER 6, 2024
The addition of samidorphan can support the antipsychotic efficacy of olanzapine while mitigating associated weight gain.
Nature study finds obesity costs US industry $347bn a year
Pharmaceutical Technology
DECEMBER 6, 2024
A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.
Treatment Options for Colon Cancer: A Guide for Pharmacists
Pharmacy Times
DECEMBER 6, 2024
Pharmacists can educate and encourage screenings for colon cancer to ensure it is discovered as early as possible.
Cell and gene therapy companies must demonstrate strong value proposition for investment         Â
Pharmaceutical Technology
DECEMBER 6, 2024
Investment for companies developing cell and gene therapies (CGTs) was discussed during the GenScript Biotech Global Forum London 2024 conference held on 20 November 2024.
Preterm Children Show Poorer Cognitive Scores, Academic Performance at 9 Years
Pharmacy Times
DECEMBER 6, 2024
Children born moderate to late preterm also showed more behavior difficulties compared with those born early term or later.
Let's personalize your content